wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37637905-19B9CB1D-BD22-4ADA-99E3-4563A3BF8236
Q37637905-19B9CB1D-BD22-4ADA-99E3-4563A3BF8236
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37637905-19B9CB1D-BD22-4ADA-99E3-4563A3BF8236
Second-Line Treatment of NSCLC-The Pan-ErbB Inhibitor Afatinib in Times of Shifting Paradigms.
P2860
Q37637905-19B9CB1D-BD22-4ADA-99E3-4563A3BF8236
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37637905-19B9CB1D-BD22-4ADA-99E3-4563A3BF8236
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e51c98f84944770ec0edbced760ea3005d2941f0
P2860
First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.